This inventor holds 1 USPTO granted patent. Top assignees: Arizona State University, Mayo Foundation for Medical Education and Research. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020
Title: Shabana Pasha: Innovator in Autoantibody Detection for Crohn's Disease
Introduction
Shabana Pasha is a notable inventor based in Scottsdale, AZ (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of autoantibodies associated with Crohn's disease. Her innovative work has the potential to enhance the diagnosis and management of this complex condition.
Latest Patents
Shabana Pasha holds a patent titled "Methods for detecting novel autoantibodies in Crohn's disease." This patent focuses on the identification of autoantibodies that are useful in diagnosing and managing Crohn's disease. The innovative protein array technology she employed, known as nucleic acid programmable protein arrays (NAPPA), has shown promising results. The study revealed that the reactivity of IgG autoantibodies was stronger than that of IgA autoantibodies. However, IgA autoantibodies demonstrated greater differential reactivity between cases and controls. Notably, four IgA autoantibodies against SNRPB, PRPH, PTTG1, and SNAI1 were newly identified, with sensitivities above 15% at 95% specificity. Among these, anti-SNRPB-IgA exhibited the highest sensitivity of 24.0%. Additionally, autoantibodies associated with specific disease subtypes were discovered.
Career Highlights
Throughout her career, Shabana Pasha has worked with esteemed institutions, including Arizona State University and the Mayo Foundation for Medical Education and Research. Her research has contributed to a deeper understanding of Crohn's disease and its associated biomarkers.
Collaborations
Shabana has collaborated with talented individuals such as Haoyu Wang and Ji Qiu, further enhancing the impact of her research in the field.
Conclusion
Shabana Pasha's innovative work in the detection of autoantibodies for Crohn's disease represents a significant advancement in medical diagnostics. Her contributions are paving the way for improved patient outcomes and a better understanding of this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile